Sterling Capital Management LLC Esperion Therapeutics, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 490 shares of ESPR stock, worth $1,092. This represents 0.0% of its overall portfolio holdings.
Number of Shares
490Holding current value
$1,092% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ESPR
# of Institutions
201Shares Held
132MCall Options Held
2.68MPut Options Held
1.29M-
Wasatch Advisors Inc Salt Lake City, UT23.3MShares$52.1 Million0.19% of portfolio
-
Black Rock Inc. New York, NY14MShares$31.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$29.1 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V89.94MShares$22.2 Million0.28% of portfolio
-
Two Seas Capital LP Rye, NY6.58MShares$14.7 Million3.65% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $148M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...